- Home
- RIOT vs NUVL Comparison
RIOT vs NUVL Comparison
Compare RIOT & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- NUVL
- Stock Information
- Founded
- RIOT 2000
- NUVL 2017
- Country
- RIOT United States
- NUVL United States
- Employees
- RIOT N/A
- NUVL 218
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- RIOT Technology
- NUVL Health Care
- Exchange
- RIOT Nasdaq
- NUVL Nasdaq
- Market Cap
- RIOT 6.3B
- NUVL 7.2B
- IPO Year
- RIOT N/A
- NUVL 2021
- Fundamental
- Price
- RIOT $20.68
- NUVL $92.96
- Analyst Decision
- RIOT Strong Buy
- NUVL Strong Buy
- Analyst Count
- RIOT 12
- NUVL 12
- Target Price
- RIOT $26.32
- NUVL $123.33
- AVG Volume (30 Days)
- RIOT 24.5M
- NUVL 572.6K
- Earning Date
- RIOT 10-30-2025
- NUVL 10-30-2025
- Dividend Yield
- RIOT N/A
- NUVL N/A
- EPS Growth
- RIOT 693.97
- NUVL N/A
- EPS
- RIOT 0.40
- NUVL N/A
- Revenue
- RIOT $637,162,000.00
- NUVL N/A
- Revenue This Year
- RIOT $81.11
- NUVL N/A
- Revenue Next Year
- RIOT $16.07
- NUVL N/A
- P/E Ratio
- RIOT $51.52
- NUVL N/A
- Revenue Growth
- RIOT 103.62
- NUVL N/A
- 52 Week Low
- RIOT $6.19
- NUVL $55.54
- 52 Week High
- RIOT $23.94
- NUVL $104.90
- Technical
- Relative Strength Index (RSI)
- RIOT 50.69
- NUVL 51.96
- Support Level
- RIOT $19.31
- NUVL $90.00
- Resistance Level
- RIOT $21.91
- NUVL $104.90
- Average True Range (ATR)
- RIOT 1.84
- NUVL 5.11
- MACD
- RIOT -0.32
- NUVL -0.44
- Stochastic Oscillator
- RIOT 37.84
- NUVL 24.76
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.